Navigation Links
GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
Date:10/17/2007

SPOKANE, Wash., Oct. 17 /PRNewswire/ -- GenPrime, Inc. a leading provider of rapid microbial analysis technologies, has initiated multi-site clinical trials of its Bacterial Contamination Test for Platelets(TM). The test is a rapid QC device for detecting the presence of aerobic and anaerobic bacteria commonly found in contaminated platelets. The trial will generate data for filing a 510 (K) pre-market notification with the Food and Drug Administration (FDA).

"Undetected bacterial contaminants in platelets tested by culture, dipsticks and other current methods remain a significant source of sepsis and associated patient mortality and morbidity in transfusion medicine," said Buck Somes, chief executive officer of GenPrime. "We believe our technology will offer a practical and rapid solution to further mitigate this problem."

Currently, over 10 million platelet units are transfused annually into patients worldwide. It is estimated by transfusion medicine experts that as many as 1 in 2000 of these units are contaminated with bacteria. While culture based tests, which can take two to three days before results are available, have reduced the chances of contaminated platelets being infused, septic reactions continue to be reported. Traditional rapid tests such as dipsticks, staining and microscopy are highly unreliable. There remains an unmet need in the transfusion industry for a sensitive, rapid, and reliable test that is user friendly and can provide accurate, objective results.

Based on a novel, easy to use, proprietary lateral flow technology platform, GenPrime's Bacterial Contamination Test for Platelets(TM) is designed to detect all 15 organisms known to contaminate platelets. Additionally GenPrime has developed an automated test reader and software for objective result analysis and data collection. The company has completed optimization, scale-up and pre-clinical studies of the test and expects to complete the clinical trial and file the 5
'/>"/>

SOURCE GenPrime, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bird Flu: Orissa Initiates Protective Measures
2. Biota Initiates Drug Testing War against Common Cold
3. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
4. Government Initiates A Program To Curb HIV
5. Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2
6. Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial
7. Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
8. The Power of External Influence on Our Lives
9. Demonstrations by staff in medical college against violence by external agencies
10. External Catheters Linked with decreased UTI Risk in Men
11. Corneal infections Linked to External Contamination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... City, NY (PRWEB) May 05, 2015 ... honors Jennifer Yates Doherty as a 2015-2016 ... Circle. She is recognized with this prestigious distinction for ... organization exclusively for professional women, boasting more than 700,000 ... pleased to welcome Jennifer into this exceptional group of ...
(Date:5/4/2015)... City, NY (PRWEB) May 05, 2015 ... honors Shirley Weis as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... recognize Shirley with this important honor,” says NAPW President ...
(Date:5/4/2015)... The American Council of Engineering ... Chairman of Stanley Consultants , to the ... for a three-year term. , ACEC co-established ISI with ... Society of Civil Engineers (ASCE). A non-profit group, ... civil infrastructure called Envision. Launched in 2012, the Envision ...
(Date:5/4/2015)... HHT is a rare but cruel ... it can have seemingly mild symptoms like frequent nosebleeds, ... Hereditary Hemorrhagic Telangiectasia (HHT) is a hereditary disorder resulting ... capillary connections between an artery and a vein. These ... but may also be present in the lungs, brain ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The ... Group today launched a new initiative at UC ... next generation of physicians committed to advancing Latino ... Ser Medicos, or Preparing Students to Be Physicians, ... that will provide scholarships, mentorship and internship opportunities, ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Jennifer Yates Doherty, Owner of Palmetto Rehabilitation Services, LLC, into its 2015 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 3Health News:Thomopulos Appointed to Institute for Sustainable Infrastructure Board 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5
... San Diego, September 12, 2011 - The Journal of ... a special 150-page four-volume digital issue featuring first-person accounts ... the morning of September 11, 2001, when terrorists invaded ... changed the way they, and most responders throughout the ...
... 12 (HealthDay News) -- Linking doctors, offices with pharmacies ... who follow doctor,s orders on medications for chronic illnesses, ... more than 12,00 men and women who were given ... over a period of 18 months. All of ...
... certain hereditary cancers develop them at earlier ages than women ... , a peer-reviewed journal of the American Cancer Society, the ... cancer diagnosis to determine when to provide counseling, screening, and ... BRCA genes have a high risk of developing breast and ...
... of the most deadly and common types of brain tumor, ... seizures and effective treatments for them have been elusive. ... has found that human gliomas implanted in mice release excess ... tumor and triggering seizures. The researchers also found that ...
... 10 (HealthDay News) -- Many U.S. college students aren,t getting ... a problem that could affect their ability to learn, a ... 200 undergraduate college students aged 18 to 24 who did ... them worked full- or part-time, and only 24 percent said ...
... in Latin America to take urgent action against preventable strokes ... year, AF increases the risk of stroke fivefold and is ... by a blood clot blocking a blood vessel in the ... from AF , In Brazil, there are around 1.5 ...
Cached Medicine News:Health News:Out of the darkness 2Health News:Linking Pharmacies With Doctors' Offices Can Improve Med Adherence: Study 2Health News:Women who inherit BRCA gene mutations develop cancer earlier than their ancestors 2Health News:NIH-funded research points to potential therapy for tumor-associated epilepsy 2Health News:NIH-funded research points to potential therapy for tumor-associated epilepsy 3Health News:Medical and patient communities call for urgent action to prevent stroke crisis in Latin America 2Health News:Medical and patient communities call for urgent action to prevent stroke crisis in Latin America 3Health News:Medical and patient communities call for urgent action to prevent stroke crisis in Latin America 4
(Date:5/4/2015)... TAIPEI , May 4, 2015 ... partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... BAX ) jointly announced that Baxter has ... European Medicines Agency (EMA) for MM-398 (irinotecan liposome ... metastatic adenocarcinoma of the pancreas who have been ...
(Date:5/4/2015)...  Makindus, Inc. a specialty pharmaceutical development company focused ... (EMA) has granted orphan drug designation for their lead ... "We are extremely pleased to now have orphan ... place for Europe . This complements ... United States for which orphan designation has ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3
... TechPrecision Corporation (OTC Bulletin Board: ... manufacturer of large-scale, high-precision metal machining fabrications and ... nuclear, defense, aerospace and other commercial industries, today ... purchase order valued at approximately $450,000.  The order, ...
... Inc. today announced that it has expanded its ... gene, CYP2C9, to further support clinicians in prescribing medications ... of the CYP2C9 gene, variations of which can cause ... psychotropic medications, provides physicians with further information on gene ...
Cached Medicine Technology:TechPrecision Corporation Receives New $450,000 Medical Purchase Order 2AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing 2AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing 3
PVC Sealing Tape, 100/Box...
Mylar Plate Sealers 100/Box...
OptiTape - Optically Clear sealing tape for OmniUltra PCR plates. 250 sheet roll....
TDX Tape - sealing sheets for polypropylene plates only, 100/PK...
Medicine Products: